Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCVSCVS Health
FinDog View：Bullish
GILDGilead Sciences
FinDog View：Neutral
| Metric | CVS | GILD |
|---|
| Close | 90.25 | 170.68 |
| Market Cap | $116B | $213B |
| 1M | +5.32% | +14.51% |
| P/E (TTM) | 23.8 | — |
| Forward P/E | 10.4 | 22.0 |
| P/E 5-Yr Percentile | 65 | — |
| P/S | 0.3 | 7.0 |
| P/B | 1.5 | 17.9 |
| Dividend Yield | 3.49% | 3.98% |
| Latest Quarter Revenue | $106B | $8.3B |
| Revenue YoY | +7.3% | +6.8% |
| Gross Margin | 44.5% | 81.1% |
| Latest Quarter EPS | 2.31 | 1.94 |
| Avg Post-Earnings Move | ±2.3% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.94% | 2.57% |
| 90-Day Net Insider Buying | — | −$15.9M |
CVS · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
